Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf377 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Kathryn Jano und 7 weiteren Autor:innen. Beteiligte Einrichtung: NYU Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Research Design, Vaccine Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Since its establishment in 1962, the Vaccine and Treatment Evaluation Units (VTEUs) have employed cutting-edge technologies to develop novel vaccines and therapeutics to mitigate emerging public health threats in the United States and globally. Clinical trial innovation has been the hallmark of these efforts as novel approaches to testing countermeasures are investigated in pace with advances in technology and evolving public health needs. The spectrum of trials conducted by the VTEUs ranges from proof-of-concept or first-in-human phase 1 to late-phase trials that establish efficacy and inform licensure decisions or “real world” vaccine usage such as with the coronavirus disease 2019 (COVID-19) and rotavirus mix-and-match trials aimed to inform standard of care. The VTEUs have also been instrumental in developing experimental wild-type challenge studies to preliminarily assess vaccine immunogenicity against influenza, shigellosis, cholera, enterotoxigenic Escherichia coli, enteropathogenic E. coli, and malaria to help select promising vaccine candidates for further development. During the COVID-19 pandemic, novel strategies for recruitment and improved accessibility of vaccine clinical trials emerged. However, the pandemic also highlighted the need for improved representation in clinical trials and underscored the importance of community engagement. As we consider what challenges to address in the upcoming years, engagement of the population in clinical trials is critical to establishing safety and efficacy and community acceptance of vaccines and therapeutics. It is imperative to develop skills that engender community advocacy while staying on the cutting edge of science, henceforth serving as the guideposts for new frontiers in clinical trial innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NYU Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA.
- Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA.
- Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Kathryn Jano, Tara M Babu, Angelica C Kottkamp, Zanthia Wiley, Angela R Branche, Karen Kotloff
Förderung
- NIAID NIH HHS
Zitieren
APA
Jano, K., Babu, T. M., Kottkamp, A. C., Rebolledo, P. A., Parameswaran, L., Wiley, Z., Branche, A. R., & Kotloff, K. (2025). Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf377
Vancouver
Jano K, Babu TM, Kottkamp AC, Rebolledo PA, Parameswaran L, Wiley Z, et al. Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf377
BibTeX
@article{Jano2025,
author = {Jano, Kathryn and Babu, Tara M and Kottkamp, Angelica C and Rebolledo, Paulina A and Parameswaran, Lalitha and Wiley, Zanthia and Branche, Angela R and Kotloff, Karen},
title = {Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf377}
}
EUVIMED